GOVX
GeoVax Labs, Inc.Company Information
- Company Name
- GeoVax Labs, Inc.
- CIK
- CIK0000832489
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GOVX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- GOVX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-10-17
- Last sale
- —
- Shares purchased (TTM)
- 43,907
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 366,629
- Shares outstanding
- 4,565,207
- Ownership
- 8.03%
Earnings Market Reaction
- Filing date
- 2026-07-27
- Price on filing date
- —
- 1-month reaction
- -15.00%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 3 | 1 | 3 | 5 | 3 | 7 | 6 | 9 | 2 | 1 | 6 | 13 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 4 | 2 | 5 | 7 | 5 | 11 | 8 | 11 | 4 | 3 | 8 | 15 | ||||||
| Accounts Receivable Net Current | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 0 | - | 0 | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Assets | 5 | 3 | 6 | 7 | 5 | 11 | 8 | 11 | 4 | 3 | 9 | 16 | ||||||
| Accounts Payable Current | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 4 | 2 | 3 | 4 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 6 | 3 | 4 | 7 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | 3 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 1 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities | 3 | 2 | 3 | - | - | - | 3 | - | - | - | - | - | ||||||
Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 162 | 157 | 155 | 151 | 143 | 143 | 134 | 130 | 113 | 110 | 110 | 106 | ||||||
| Retained Earnings Accumulated Deficit | -161 | -156 | -151 | -146 | -140 | -135 | -129 | -121 | -115 | -110 | -104 | -97 | ||||||
| Stockholders Equity | 2 | 0 | 4 | 5 | 3 | 8 | 5 | 9 | -2 | 0 | 6 | 9 | ||||||
| Liabilities And Stockholders Equity | 5 | 3 | 6 | 7 | 5 | 11 | 8 | 11 | 4 | 3 | 9 | 16 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 600 | 600 | ||||||
| Shares Outstanding | 7 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 7 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGeoVax Labs, Inc. (GOVX) — SEC Financial Statements & Analysis
GeoVax Labs, Inc. (GOVX) is a pharmaceutical preparations company, incorporated in DE. GeoVax Labs, Inc. trades on Nasdaq as: GOVX. GeoVax Labs, Inc. (GOVX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-27. Based on that filing, GeoVax Labs, Inc. carries a market cap of $5.80M, a P/E ratio of -0.28x, a P/B ratio of 3.29x, a P/S ratio of 3.25x, an enterprise value of $2.65M, and an EV/EBITDA multiple of -0.13x. On profitability, it posts an operating margin of -2523.43%, a net margin of -2507.27%, a Return on Equity (ROE) of -891.59%, a Return on Assets (ROA) of -408.80%, and a Return on Invested Capital (ROIC) of -10559.25%. Per share, it reports EPS of $-4.47, free cash flow per share of $-4.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -17.66% year-over-year, and EPS growth of -88.92% year-over-year. On the balance sheet, it maintains a current ratio of 1.54x, a quick ratio of 1.16x, working capital of $1.46M, a debt-to-equity ratio of 1.64x, a debt ratio of 0.62, an interest coverage ratio of -1776.83x, free cash flow of $-18.38M (TTM), and net debt of $-3.14M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.80M
- P/E TTM
- -0.28x
- EPS TTM
- $-4.47
- P/B TTM
- 3.29x
- ROE TTM
- -891.59%
- ROA TTM
- -408.80%
- Debt To Equity
- 1.64x
- Free Cash Flow TTM
- $-18.38M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GeoVax Labs, Inc. in?
GeoVax Labs, Inc. (GOVX) operates in the Pharmaceutical Preparations industry.
What exchange does GOVX trade on?
GeoVax Labs, Inc. (GOVX) trades on the Nasdaq.
Where is GeoVax Labs, Inc. incorporated?
GeoVax Labs, Inc. is incorporated in DE.
When was GeoVax Labs, Inc. (GOVX)'s most recent SEC filing?
GeoVax Labs, Inc. (GOVX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-27.
What is GOVX's market cap?
GeoVax Labs, Inc. (GOVX) has a market capitalization of $5.80M as of 2026-06-30.
What is GOVX's EPS (earnings per share)?
GeoVax Labs, Inc. (GOVX)'s trailing twelve month EPS is $-4.47 as of 2026-06-30.
What is GOVX's ROE (return on equity)?
GeoVax Labs, Inc. (GOVX)'s trailing twelve month Return on Equity (ROE) is -891.59% as of 2026-06-30.
What is GOVX's ROA (return on assets)?
GeoVax Labs, Inc. (GOVX)'s trailing twelve month Return on Assets (ROA) is -408.80% as of 2026-06-30.
What is GOVX's ROIC (return on invested capital)?
GeoVax Labs, Inc. (GOVX)'s trailing twelve month Return on Invested Capital (ROIC) is -10559.25% as of 2025-12-31.
What is GOVX's EV/EBITDA?
GeoVax Labs, Inc. (GOVX)'s trailing twelve month EV/EBITDA is -0.13x as of 2026-06-30.